Home2020-06-23T13:37:30+00:00

Less Task, More Talk

How Can We Help You

PERSIST™ Software Features

LEAD CONVERSION

Here’s how easy it can work for your business… #1 – You provide us with your unconverted leads. #2 – We then process your leads through our system and refer converted leads back to your business.

Please fill our form below for more information.

How Can We Help You

Schedule A Live Demo or Free Consultation

The old, manual way is a thing of the past.
The time is now to try the PERSIST way.

Taking the time to screen new customers is time-consuming and takes you away from other, more important tasks. Let our team of seasoned experts and our proven methods help you grow your business.

Contact us for a free consultation today at 1-866-473-7747.

105, 2019

Invokana for Type 2 Diabetes Poses Health Risks

By |May 1st, 2019|

Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, developed Invokana to treat Type 2 diabetes. Invokana is a sodium-glucose co-transporter 2 (SGLT2) inhibitor designed to help control blood sugar levels in adults. The medication works by inhibiting some kidney functions [...]

2403, 2017

Leading a Healthy Lifestyle Infographic

By |March 24th, 2017|

Good nutrition combined with physical activity are an important part of leading a healthy lifestyle. Your diet can help you to reach and maintain a healthy weight, reduce your risk of chronic diseases and promote your overall health.

2401, 2017

Google Updated Algorithm

By |January 24th, 2017|

GOOGLE UPDATED ITS ALGORITHM AGAIN – WHY DO I CARE? Many of us have heard about Google updating, but may not be sure what that means or if it even affects you or your business. Fortunately, or unfortunately, it certainly [...]

2707, 2016

LATEST ON JOHNSON & JOHNSON AND THE RISPERDAL LAWSUIT

By |July 27th, 2016|

In a Philadelphia court, Johnson & Johnson (J&J) just paid out its largest award yet, $70 million for their prescription drug Risperdal (Risperidone). Criminal charges are tied to allegations that the company marketed the drug for off-label use. Off-label use [...]